Yi Larson is a biotech founder and currently serves as the President and CEO of Expedition Therapeutics. Her career includes significant leadership positions within the healthcare and finance sectors.

Prior to her current role, Larson was the Chief Financial Officer and Chief Compliance Officer at Lianbio, and also held the position of Chief Financial Officer at Turning Point Therapeutics. She brings a strong financial background from her time as a Managing Director at Goldman Sachs.